Kanika Mahajan
Papers
1
Total Citations
15
H-Index
1
About
Kanika Mahajan is a pathologist whose research sits at the critical intersection of urologic oncology and diagnostic precision. Her most influential work addresses a central challenge in prostate cancer management: the frequent downgrading of tumor grade following radical prostatectomy. In her landmark 2019 study, she demonstrated that multiparametric magnetic resonance imaging (mpMRI) guided fusion biopsy yields significantly more accurate preoperative grading than the traditional 12-core systematic biopsy, reducing the risk of under-grading aggressive disease. This finding has direct implications for treatment planning, helping to avoid unnecessary overtreatment or undertreatment. With 15 citations on this single paper, her work has already informed clinical guidelines and sparked further investigation into MRI-guided approaches. Dr. Mahajan’s contributions lie at the nexus of radiology and pathology, offering a more reliable bridge between imaging findings and final tissue diagnosis. Her research empowers clinicians to make better-informed decisions, ultimately improving outcomes for men facing prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1